Literature DB >> 17439225

Synthesis of L-kedarosamine in protected form and its efficient incorporation into an advanced intermediate to kedarcidin chromophore.

Feng Ren1, Philip C Hogan, Alan J Anderson, Andrew G Myers.   

Abstract

An efficient route to the complex L-kedarosamine alpha-glycosidic ether 2, a synthetic precursor to kedarcidin chromophore, is described. Central to the route, which is suitable for the preparation of multigram amounts of material, is a short synthetic sequence from D-threonine to protected L-kedarosamine derivatives and methodology for their alpha-selective coupling with appropriate hydroxyl acceptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17439225      PMCID: PMC3176327          DOI: 10.1021/ol070450x

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  10 in total

1.  Synthesis of the Kedarcidin Core Structure by a Transannular Cyclization Pathway Financial support from the National Institutes of Health is gratefully acknowledged.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  2000-08-04       Impact factor: 15.336

2.  Enantioselective synthesis of kedarcidin chromophore aglycon in differentially protected form.

Authors:  Andrew G Myers; Philip C Hogan; Alexander R Hurd; Steven D Goldberg
Journal:  Angew Chem Int Ed Engl       Date:  2002-03-15       Impact factor: 15.336

3.  Kedarcidin, a new chromoprotein antitumor antibiotic. II. Isolation, purification and physico-chemical properties.

Authors:  S J Hofstead; J A Matson; A R Malacko; H Marquardt
Journal:  J Antibiot (Tokyo)       Date:  1992-08       Impact factor: 2.649

4.  Kedarcidin, a new chromoprotein antitumor antibiotic. I. Taxonomy of producing organism, fermentation and biological activity.

Authors:  K S Lam; G A Hesler; D R Gustavson; A R Crosswell; J M Veitch; S Forenza; K Tomita
Journal:  J Antibiot (Tokyo)       Date:  1991-05       Impact factor: 2.649

5.  Evidence for facile atropisomerism and simple (non-nucleophilic) biradical-forming cycloaromatization within kedarcidin chromophore aglycon.

Authors:  Andrew G Myers; Alexander R Hurd; Philip C Hogan
Journal:  J Am Chem Soc       Date:  2002-05-01       Impact factor: 15.419

6.  Efficient construction of the kedarcidin chromophore ansamacrolide.

Authors:  Yasuhito Koyama; Martin J Lear; Fumihiko Yoshimura; Isao Ohashi; Tomoko Mashimo; Masahiro Hirama
Journal:  Org Lett       Date:  2005-01-20       Impact factor: 6.005

7.  Structure of the new spiroketal-macrolide A82548A.

Authors:  H A Kirst; S H Larsen; J W Paschal; J L Occolowitz; L C Creemer; J L Steiner; E Lobkovsky; J Clardy
Journal:  J Antibiot (Tokyo)       Date:  1995-09       Impact factor: 2.649

8.  Selective proteolytic activity of the antitumor agent kedarcidin.

Authors:  N Zein; A M Casazza; T W Doyle; J E Leet; D R Schroeder; W Solomon; S G Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  Kedarcidin chromophore: an enediyne that cleaves DNA in a sequence-specific manner.

Authors:  N Zein; K L Colson; J E Leet; D R Schroeder; W Solomon; T W Doyle; A M Casazza
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

10.  Use of polystyrene-supported DBU in the synthesis and alpha-selective glycosylation study of the unstable Schmidt donor of L-kedarosamine.

Authors:  Isao Ohashi; Martin J Lear; Fumihiko Yoshimura; Masahiro Hirama
Journal:  Org Lett       Date:  2004-03-04       Impact factor: 6.005

  10 in total
  1 in total

1.  De Novo Synthesis of an l-Lemonose Thioglycoside Donor from d-Threonine.

Authors:  Eric D Huseman; Steven D Townsend
Journal:  Tetrahedron Lett       Date:  2021-04-22       Impact factor: 2.032

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.